Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4524939

NC(=O)N1CCCCC1.O=C(O)C(F)(F)F

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
F2 P00734 1/20 0.39
MLYCD O95822 2/20 0.39
HPGD P15428 5/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
DPP4 P27487 4/20 0.37
DPP8 Q6V1X1 3/20 0.37
DPP7 Q9UHL4 2/20 0.36
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
MMP9 P14780 1/20 0.35
DPP9 Q86TI2 1/20 0.35
CA2 P00918 1/20 0.34
CHKA P35790 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL30657126 0.93 MLYCD (0.36) ALDH1A1MLYCDDPP4DPP8DPP7
Trifluoroacetic Acid SCHEMBL21410151 0.93 MLYCD (0.36) ALDH1A1MLYCDDPP4DPP8DPP7
SCHEMBL5457 0.83
SCHEMBL8364865 0.83 ALDH1A1 (0.55) ALDH1A1F2HPGDMEN1KMT2A
SCHEMBL2778162 0.83 ALDH1A1 (0.55) ALDH1A1F2HPGDMEN1KMT2A
SCHEMBL23963672 0.83 ALDH1A1 (0.55) ALDH1A1F2HPGDMEN1KMT2A
SCHEMBL1363949 0.83
SCHEMBL4129583 0.83 ALDH1A1 (0.55) ALDH1A1F2HPGDMEN1KMT2A
SCHEMBL7749269 0.83 ALDH1A1 (0.55) ALDH1A1F2HPGDMEN1KMT2A
SCHEMBL14511334 0.83 ALDH1A1 (0.55) ALDH1A1F2HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220281815-A1 CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS Jubilant Epicore LLC 2022-09-08 US claimed
CN-107592861-B Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof 法玛克亚公司 2021-06-08 CN disclosed
CN-106715440-B Imidazo isoindoles derivative, preparation method and its application in medicine 江苏恒瑞医药股份有限公司 2019-02-22 CN disclosed
CN-107428719-A 4-methylsulfonyl substituted piperidine urea compounds for the treatment of Dilated Cardiomyopathy (DCM) 迈奥卡迪亚公司 2017-12-01 CN disclosed
CN-106715440-A Imidazo isoindole derivative, preparation method therefor and medical use thereof 江苏恒瑞医药股份有限公司 2017-05-24 CN disclosed
US-20090326003-A1 PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORS GLAXO GROUP LIMITED (GB) 2009-12-31 US disclosed
EP-1263755-A2 CYCLIC BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA Bristol-Myers Squibb Pharma Company (US) 2002-12-11 EP disclosed
WO-2001070673-A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326003-A1 PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PDE4 INHIBITORS PDE4A, PDE4B, PDE12 ALDH1A1 692/4885F2 3224/4885MLYCD 4485/4885
US-20220281815-A1 CYCLOPROPYL-AMIDE COMPOUNDS AS DUAL LSD1/HDAC INHIBITORS HDAC1, HDAC11, HDAC2 ALDH1A1 821/4885F2 4823/4885MLYCD 2880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.